Skip to content

Clinical trials

Phase 4 Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 4 Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20033
20044
20052
20063
20074
20092
20102
20112
20122
20136
20144
20154
20161
20174
20183
20191
20201
20214
20222
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Unknown status9
Terminated5
Withdrawn4
Recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute5
University of Pittsburgh4
University of North Carolina, Chapel Hill3
GlaxoSmithKline2
Massachusetts General Hospital2
Mayo Clinic2
National Institute of Mental Health (NIMH)2
Shanghai Mental Health Center2
Washington University School of Medicine2
Weill Medical College of Cornell University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder64
Major Depressive Disorder13
Bipolar Disorder7
Mood Disorders7
Mental Disorders4
Anxiety Disorders3
Depressive Disorder, Treatment-Resistant3
Alzheimer Disease2
Dysthymic Disorder2
Angina, Unstable1

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.